Search filters

List of works by Don L Gibbons

18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer

scientific article published on 16 April 2020

A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer

scientific article published on 05 October 2020

A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components

scientific article published on 01 September 2020

Comprehensive T cell repertoire characterization of non-small cell lung cancer

scientific article published on 30 January 2020

Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy

scientific article published on 12 April 2022

MBIP (MAP3K12 binding inhibitory protein) drives NSCLC metastasis by JNK-dependent activation of MMPs

scientific article published on 22 September 2020

Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy.

scientific article published on 18 February 2014

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

scientific article published on 18 February 2021

Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer

scientific article published on 19 August 2021

Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.

scientific article

PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma

scientific article published on 01 January 2020

Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively

scientific article published on 27 June 2020

The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics

scientific article published on 06 December 2021

Through the open door: Preferential binding of dasatinib to the active form of BCR-ABL unveiled by in silico experiments

scientific article published on 15 June 2013

ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism

scientific article published on 01 March 2019